Hidetaka Takashima

620 total citations
15 papers, 429 citations indexed

About

Hidetaka Takashima is a scholar working on Hepatology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Hidetaka Takashima has authored 15 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 5 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Hidetaka Takashima's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer Research and Treatments (2 papers). Hidetaka Takashima is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer Research and Treatments (2 papers). Hidetaka Takashima collaborates with scholars based in Japan. Hidetaka Takashima's co-authors include Takeshi Okanoue, Tomoki Nakajima, Michihisa Moriguchi, Tatsuo Katagishi, Yoshito Itoh, Satoru Sekoguchi, Hiroyuki Kimura, Keizo Kagawa, Taichiro Nishikawa and Masahito Minami and has published in prestigious journals such as Oncogene, Biochemical and Biophysical Research Communications and Journal of Hepatology.

In The Last Decade

Hidetaka Takashima

13 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hidetaka Takashima Japan	7	149	99	96	81	76	15	429
Wenxia Lu China	9	124 0.8×	196 2.0×	43 0.4×	51 0.6×	140 1.8×	13	468
Masayasu Jo Japan	9	126 0.8×	150 1.5×	83 0.9×	54 0.7×	97 1.3×	13	452
Chung-Kwe Wang Taiwan	12	222 1.5×	129 1.3×	87 0.9×	49 0.6×	219 2.9×	12	617
Bora Akoglu Germany	10	254 1.7×	44 0.4×	60 0.6×	98 1.2×	27 0.4×	16	571
Mohamed O. Mahmoud Egypt	13	200 1.3×	100 1.0×	47 0.5×	55 0.7×	68 0.9×	24	575
Stefania Asciutti Italy	11	148 1.0×	46 0.5×	113 1.2×	89 1.1×	24 0.3×	18	407
Youngsic Jeon South Korea	16	190 1.3×	47 0.5×	52 0.5×	64 0.8×	33 0.4×	29	498
A Mahli Germany	12	193 1.3×	158 1.6×	71 0.7×	72 0.9×	60 0.8×	21	472
Toshitsugu Oda Japan	12	224 1.5×	131 1.3×	39 0.4×	66 0.8×	100 1.3×	32	617

Countries citing papers authored by Hidetaka Takashima

Since Specialization

Citations

This map shows the geographic impact of Hidetaka Takashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetaka Takashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetaka Takashima more than expected).

Fields of papers citing papers by Hidetaka Takashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetaka Takashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetaka Takashima. The network helps show where Hidetaka Takashima may publish in the future.

Co-authorship network of co-authors of Hidetaka Takashima

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetaka Takashima. A scholar is included among the top collaborators of Hidetaka Takashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetaka Takashima. Hidetaka Takashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Takashima, Hidetaka, Michihisa Moriguchi, Natsuko Hayashi, et al.. (2020). A Simple Method to Avoid Bile Duct Injury during Percutaneous Radiofrequency Ablation Therapy for Hepatocellular Carcinoma. Case Reports in Oncology. 13(3). 1337–1342. 1 indexed citations

Takashima, Hidetaka, Michihisa Moriguchi, Kohichiroh Yasui, et al.. (2020). Procedure of Direct Hepatic Artery Puncture for the Treatment of Hepatocellular Carcinoma: Two Case Reports. Case Reports in Oncology. 13(1). 414–418.

Takashima, Hidetaka, Shigeto Mizuno, Takahiro Mori, et al.. (2019). A patient with argininosuccinate synthase 1 positive unclassified hepatocellular adenoma causing intratumoral hemorrhage. Kanzo. 60(9). 338–346.

Kikuchi, Kaori, Hidetaka Takashima, Takahiro Mori, et al.. (2017). Percutaneous transhepatic intra-arterial ethanol injection therapy for ruptured hepatocellular carcinoma. Kanzo. 58(9). 510–518. 1 indexed citations

Yasui, Kohichiroh, Hidetaka Takashima, Toshiya Ochiai, et al.. (2012). Selective accumulation of platinum and formation of platinum–DNA adducts in hepatocellular carcinoma after transarterial chemoembolization with miriplatin. Hepatology Research. 43(10). 1093–1099. 5 indexed citations

Takashima, Hidetaka, et al.. (2011). Percutaneous transhepatic artery chemolipiodolization for multiple hepatocellular carcinomas. Kanzo. 52(10). 687–694. 2 indexed citations

Takashima, Hidetaka, Yoshiki Murakami, Takeshi Nishikawa, et al.. (2010). A case of resection of hepatocellular carcinoma associated with primary biliary cirrhosis (PBC) who had prior infection with HBV. Kanzo. 51(10). 557–564. 1 indexed citations

Nishikawa, Taichiro, Tomoki Nakajima, Michihisa Moriguchi, et al.. (2005). A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. Journal of Hepatology. 44(6). 1074–1082. 146 indexed citations

Takashima, Hidetaka, Tomoki Nakajima, Michihisa Moriguchi, et al.. (2005). In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma. Liver International. 25(1). 77–84. 26 indexed citations

10.

Minami, Masahito, Kojiro Mori, Hidetaka Takashima, et al.. (2005). Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis. Oncogene. 24(27). 4340–4348. 66 indexed citations

11.

Nakajima, Tomoki, Michihisa Moriguchi, Tatsuo Katagishi, et al.. (2005). Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD. Liver International. 26(1). 23–31. 58 indexed citations

12.

Nakajima, Tomoki, Tatsuo Katagishi, Michihisa Moriguchi, et al.. (2004). Tumor size-independence of telomere length indicates an aggressive feature of HCC. Biochemical and Biophysical Research Communications. 325(4). 1131–1135. 8 indexed citations

13.

Nakajima, Tomoki, Michihisa Moriguchi, Yasuhide Mitsumoto, et al.. (2004). Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma. Modern Pathology. 17(6). 722–727. 29 indexed citations

14.

Moriguchi, Michihisa, Tomoki Nakajima, Tadashi Watanabe, et al.. (2002). The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin‐8 production. International Journal of Cancer. 102(5). 445–452. 83 indexed citations

15.

Takashima, Hidetaka, et al.. (2002). [A case of AFP producing endocrine cell carcinoma of the duodenum].. PubMed. 99(7). 798–802. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact